US Federal Circuit Breathes Life Into Viatris Symbicort Challenge
Company’s Stipulated Judgment Of Infringement Is Vacated And Remanded
Viatris may be able to move earlier than anticipated with its Breyna proposed generic version of Symbicort, after the US Court of Appeals for the Federal Circuit found that a lower court had misinterpreted claims of Symbicort patents for which Viatris has stipulated to infringement.
